Abstract:Chemotherapy during pregnancy can increase the risk of fetal anemia. Severe fetal anemia can lead to the development of hydrops fetalis and potentially fetal demise. Middle cerebral artery – peak systolic velocity (MCA‐PSV) was used to identify fetal anemia. The patients were scheduled for ultrasound examinations of the MCA‐PSV. When anemia was identified, chemotherapy was individually modified. Using MCA‐PSV we are able to monitor fetal anemia and tailor the patient's treatment to ensure optimal oncological treatment without endangering maternal safety and to optimize fetal outcomes. Introduction Chemotherapy during pregnancy can increase the risk of fetal anemia. Severe fetal anemia can lead to the development of hydrops fetalis and potentially fetal demise. Hence, it is imperative to implement consistent monitoring methods in the context of chemotherapy treatment. This study aimed to diagnose and monitor fetal anemia using middle cerebral artery peak systolic velocity (MCA‐PSV) as a diagnostic tool during chemotherapy in pregnant women. Material and methods The study employed a prospective analysis involving a case series of 15 patients diagnosed with cancer during pregnancy and subsequently underwent chemotherapy. MCA‐PSV was used to identify fetal anemia. The patients were scheduled for ultrasound examinations of the MCA‐PSV. The first examination was performed on the same day as the administration of chemotherapy, while the second occurred on the 10th day after chemotherapy. The measurement technique used in the study was based on the methodology proposed by Mari and Barr. The multiples of the median were calculated using the calculators provided by Medicina Fetal Barcelona. Based on these values anemia severity was determined. When moderate or severe anemia was identified, chemotherapy was individually modified. Additionally, a blood count analysis was conducted immediately after the delivery of the newborn. Results Five patients were diagnosed with fetal or newborn anemia. With MCA‐PSV, we identified moderate fetal anemia in two patients and severe fetal anemia in one. The complete blood count testing of newborns revealed mild anemia in three patients. One case was unrelated to chemotherapy‐induced anemia. During treatment, fetal anemia did not corelate with maternal anemia. Conclusions In four cases of anemia the combination of cisplatin and iphosphamide was used as a chemotherapy agent. No anemia was observed in other drug combinations. Our findings suggest that MCA‐PSV is a reliable method for identifying anemia and should be included in the treatment protocol for chemotherapy‐induced fetal anemia.

Elevated Middle Cerebral Artery Peak systolic velocity in non-anemic fetuses - Providing a better understanding of enigmatic Middle Cerebral Artery Peak systolic velocity

Z-scores of Early Diastolic Blood Flow Widths of Mitral and Tricuspid Valves in Normal Fetuses and Fetuses with Dilated Coronary Sinus

OC09.05: A Quantitative Study of Fetal Diastolic Ventricular Function: Establishing Normal Values of Color M‐mode Propagation Velocity

Umbilical and middle cerebral arteries Doppler velocimetry in early and late onset pre-eclampsia

Using Doppler Measurement of Fetal Middle Cerebral Artery Peak Systolic Velocity on Prediction of Fetal Anemia

Severe Neonatal Anemia Affected by Massive Fetomaternal Hemorrhage: a Single-Center Retrospective Observational Study

Clinical Significance of Mild Fetal Ventriculomegaly by Prenatal Ultrasonography Examination

Doppler ultrasonographic assessment of fetal middle cerebral artery peak systolic velocity in gestational diabetes mellitus

Middle cerebral artery peak systolic velocity monitoring of fetal anemia during chemotherapy in pregnancy

Using Middle Cerebral Artery Doppler Ultrasound to Predict Clinical Chorioamnionitis After Preterm Prelabor Rupture of Membranes

MRI Characterization of Hemodynamic Patterns of Human Fetuses with Cyanotic Congenital Heart Disease

Postnatal cerebral hemodynamics and placental vascular malperfusion lesions in neonates with congenital heart disease

P182 AORTIC VASCULAR BIOMARKERS FOR THE EARLY DETECTION OF PLACENTAL SYNDROMES DURING PREGNANCY: A SYSTEMATIC REVIEW AND META-ANALYSIS

Relationship between fetal middle cerebral artery pulsatility index and cerebroplacental ratio with adverse neonatal outcomes in low-risk pregnancy candidates for elective cesarean section: A cross-sectional study

Umbilical and Middle Cerebral Artery Doppler Measurements in Fetuses With Congenital Heart Block

A maternal meal affects clinical Doppler parameters in the fetal middle cerebral artery

Foetal cerebral blood redistribution in idiopathic polyhydramnios and the impact on perinatal outcomes

Middle Cerebral Artery Doppler before and after Fetal Spina Bifida Repair: An Indirect Sign of Hindbrain Compression and Decompression?

Fetal and Neonatal Middle Cerebral Artery Hemodynamic Changes and Significance under Ultrasound Detection in Hypertensive Disorder Complicating Pregnancy Patients with Different Severities

Cerebrovascular hemodynamics in fetuses with congenital heart disease.

Predicting Adverse Outcomes in Monochorionic-Diamniotic Twins: The Role of Intertwin Discrepancy in Middle Cerebral Artery Doppler Measurements and the Cerebroplacental Ratio